Wiley Matthew T. — SEC insider filings
SEC reporting owner CIK 1759703. 21 insider filings on record with FilingPulse; latest filed 2026-09-29.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2020-10-02 to 2026-09-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 13,703 shares, $248,921 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 2,867 shares @ $45.03 ($129,101) in Definium Therapeutics, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 7 | — | 2 legs · 5,964 sh · $242,358 | 5 |
| BioXcel Therapeutics, Inc. (BTAI) | — | 8 | — | 4 legs · 7,739 sh · $6,562 | 12 |
| VYNE Therapeutics Inc. (VYNE) | Chief Commercial Officer | 6 | — | — | 7 |
Insider filings — Wiley Matthew T.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-29 | 4 | Definium Therapeutics, Inc. (DFTX) | Sale (S): 3,097 @ $36.57 | EDGAR |
| 2026-09-14 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-08-12 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2026-06-26 | 4 | Definium Therapeutics, Inc. (DFTX) | Sale (S): 2,867 @ $45.03 | EDGAR |
| 2026-06-22 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2026-02-05 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 115,000 @ $0 | EDGAR |
| 2025-04-01 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Grant/award (A): 1,875 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Grant/award (A): 21,250 · Sale (S): 6,272 @ $0.55 | EDGAR |
| 2024-09-17 | 4/A | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 750 · Sale (S): 215 @ $0.69 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 750 · Sale (S): 244 @ $1.26 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Option exercise (M): 3,000 · Sale (S): 1,008 @ $2.64 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Grant/award (A): 12,000 (derivative) @ $0 · Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2022-01-19 | 4 | BioXcel Therapeutics, Inc. (BTAI) | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 5,151 @ $3.51 | EDGAR |
| 2021-04-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 2,573 @ $6.84 | EDGAR |
| 2021-02-24 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 27,675 @ $0 · Grant/award (A): 64,575 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 1,541 @ $1.58 | EDGAR |
| 2020-12-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Grant/award (A): 7,838 @ $1.45 | EDGAR |
| 2020-10-02 | 4 | VYNE Therapeutics Inc. (VYNE) | Tax withholding (F): 1,541 @ $1.66 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1759703 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs